Cargando…
Screening of Potential Probiotic Lactobacillaceae and Their Improvement of Type 2 Diabetes Mellitus by Promoting PI3K/AKT Signaling Pathway in db/db Mice
The study aimed to isolate Lactobacillaceae strains with in vitro hypoglycemic activity and probiotic properties and to determine their antidiabetic abilities in vivo. Lactiplantibacillus plantarum 22, L. plantarum 25, Limosilactobacillus fermentum 11, and L. fermentum 305 with high in vitro hypogly...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508973/ https://www.ncbi.nlm.nih.gov/pubmed/37725896 http://dx.doi.org/10.33073/pjm-2023-028 |
_version_ | 1785107639782342656 |
---|---|
author | Li, Yueyang Tong, Tong Li, Peifan Peng, Yian Zhang, Michael Liu, Jia She, Yongxin Li, Zuming Li, Yongli |
author_facet | Li, Yueyang Tong, Tong Li, Peifan Peng, Yian Zhang, Michael Liu, Jia She, Yongxin Li, Zuming Li, Yongli |
author_sort | Li, Yueyang |
collection | PubMed |
description | The study aimed to isolate Lactobacillaceae strains with in vitro hypoglycemic activity and probiotic properties and to determine their antidiabetic abilities in vivo. Lactiplantibacillus plantarum 22, L. plantarum 25, Limosilactobacillus fermentum 11, and L. fermentum 305 with high in vitro hypoglycemic activity were screened from 23 strains of Lactobacillaceae isolated from human feces and identified by 16S rDNA sequencing. The fasting blood glucose (FBG) of the mice was recorded weekly. After 12 weeks, liver, kidney, and pancreas tissues were stained with hematoxylin and eosin (H&E) to observe histomorphology; the inflammatory factors were assayed by Quantitative Real-time PCR; PI3K and AKT were measured by Western blot; the short-chain fatty acids (SCFAs) were determined by LC-MS/MS. Inhibitory activities of L. plantarum 22, L. plantarum 25, L. fermentum 11, and L. fermentum 305 against α-amylase were 62.29 ± 0.44%, 51.81 ± 3.65%, 58.40 ± 1.68%, and 57.48 ± 5.04%, respectively. Their inhibitory activities to α-glucosidase were 14.89 ± 0.38%, 15.32 ± 0.89%, 52.63 ± 3.07%, and 51.79 ± 1.13%, respectively. Their survival rate after simulated gastrointestinal test were 12.42 ± 2.84%, 9.10 ± 1.12%, 5.86 ± 0.52%, and 8.82 ± 2.50% and their adhesion rates to Caco-2 cell were 6.09 ± 0.39%, 6.37 ± 0.28%, 6.94 ± 0.27%, and 6.91 ± 0.11%, respectively. The orthogonal tests of bacterial powders of the four strains showed that the maximum inhibitory activities to α-amylase and α-glucosidase were 93.18 ± 1.19% and 75.33 ± 2.89%, respectively. The results showed that the mixture of Lactobacillaceae could lower FBG, reduce inflammation, and liver, kidney, and pancreas damage, promote PI3K/AKT signaling pathway, and increase the content of SCFAs. The combination of L. plantarum 22, L. plantarum 25, L. fermentum 11, and L. fermentum 305 can potentially improve type 2 diabetes mellitus (T2DM). [Figure: see text] |
format | Online Article Text |
id | pubmed-10508973 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Sciendo |
record_format | MEDLINE/PubMed |
spelling | pubmed-105089732023-09-20 Screening of Potential Probiotic Lactobacillaceae and Their Improvement of Type 2 Diabetes Mellitus by Promoting PI3K/AKT Signaling Pathway in db/db Mice Li, Yueyang Tong, Tong Li, Peifan Peng, Yian Zhang, Michael Liu, Jia She, Yongxin Li, Zuming Li, Yongli Pol J Microbiol Original Paper The study aimed to isolate Lactobacillaceae strains with in vitro hypoglycemic activity and probiotic properties and to determine their antidiabetic abilities in vivo. Lactiplantibacillus plantarum 22, L. plantarum 25, Limosilactobacillus fermentum 11, and L. fermentum 305 with high in vitro hypoglycemic activity were screened from 23 strains of Lactobacillaceae isolated from human feces and identified by 16S rDNA sequencing. The fasting blood glucose (FBG) of the mice was recorded weekly. After 12 weeks, liver, kidney, and pancreas tissues were stained with hematoxylin and eosin (H&E) to observe histomorphology; the inflammatory factors were assayed by Quantitative Real-time PCR; PI3K and AKT were measured by Western blot; the short-chain fatty acids (SCFAs) were determined by LC-MS/MS. Inhibitory activities of L. plantarum 22, L. plantarum 25, L. fermentum 11, and L. fermentum 305 against α-amylase were 62.29 ± 0.44%, 51.81 ± 3.65%, 58.40 ± 1.68%, and 57.48 ± 5.04%, respectively. Their inhibitory activities to α-glucosidase were 14.89 ± 0.38%, 15.32 ± 0.89%, 52.63 ± 3.07%, and 51.79 ± 1.13%, respectively. Their survival rate after simulated gastrointestinal test were 12.42 ± 2.84%, 9.10 ± 1.12%, 5.86 ± 0.52%, and 8.82 ± 2.50% and their adhesion rates to Caco-2 cell were 6.09 ± 0.39%, 6.37 ± 0.28%, 6.94 ± 0.27%, and 6.91 ± 0.11%, respectively. The orthogonal tests of bacterial powders of the four strains showed that the maximum inhibitory activities to α-amylase and α-glucosidase were 93.18 ± 1.19% and 75.33 ± 2.89%, respectively. The results showed that the mixture of Lactobacillaceae could lower FBG, reduce inflammation, and liver, kidney, and pancreas damage, promote PI3K/AKT signaling pathway, and increase the content of SCFAs. The combination of L. plantarum 22, L. plantarum 25, L. fermentum 11, and L. fermentum 305 can potentially improve type 2 diabetes mellitus (T2DM). [Figure: see text] Sciendo 2023-09-20 /pmc/articles/PMC10508973/ /pubmed/37725896 http://dx.doi.org/10.33073/pjm-2023-028 Text en © 2023 Yueyang Li et al., published by Sciendo https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. |
spellingShingle | Original Paper Li, Yueyang Tong, Tong Li, Peifan Peng, Yian Zhang, Michael Liu, Jia She, Yongxin Li, Zuming Li, Yongli Screening of Potential Probiotic Lactobacillaceae and Their Improvement of Type 2 Diabetes Mellitus by Promoting PI3K/AKT Signaling Pathway in db/db Mice |
title | Screening of Potential Probiotic Lactobacillaceae and Their Improvement of Type 2 Diabetes Mellitus by Promoting PI3K/AKT Signaling Pathway in db/db Mice |
title_full | Screening of Potential Probiotic Lactobacillaceae and Their Improvement of Type 2 Diabetes Mellitus by Promoting PI3K/AKT Signaling Pathway in db/db Mice |
title_fullStr | Screening of Potential Probiotic Lactobacillaceae and Their Improvement of Type 2 Diabetes Mellitus by Promoting PI3K/AKT Signaling Pathway in db/db Mice |
title_full_unstemmed | Screening of Potential Probiotic Lactobacillaceae and Their Improvement of Type 2 Diabetes Mellitus by Promoting PI3K/AKT Signaling Pathway in db/db Mice |
title_short | Screening of Potential Probiotic Lactobacillaceae and Their Improvement of Type 2 Diabetes Mellitus by Promoting PI3K/AKT Signaling Pathway in db/db Mice |
title_sort | screening of potential probiotic lactobacillaceae and their improvement of type 2 diabetes mellitus by promoting pi3k/akt signaling pathway in db/db mice |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508973/ https://www.ncbi.nlm.nih.gov/pubmed/37725896 http://dx.doi.org/10.33073/pjm-2023-028 |
work_keys_str_mv | AT liyueyang screeningofpotentialprobioticlactobacillaceaeandtheirimprovementoftype2diabetesmellitusbypromotingpi3kaktsignalingpathwayindbdbmice AT tongtong screeningofpotentialprobioticlactobacillaceaeandtheirimprovementoftype2diabetesmellitusbypromotingpi3kaktsignalingpathwayindbdbmice AT lipeifan screeningofpotentialprobioticlactobacillaceaeandtheirimprovementoftype2diabetesmellitusbypromotingpi3kaktsignalingpathwayindbdbmice AT pengyian screeningofpotentialprobioticlactobacillaceaeandtheirimprovementoftype2diabetesmellitusbypromotingpi3kaktsignalingpathwayindbdbmice AT zhangmichael screeningofpotentialprobioticlactobacillaceaeandtheirimprovementoftype2diabetesmellitusbypromotingpi3kaktsignalingpathwayindbdbmice AT liujia screeningofpotentialprobioticlactobacillaceaeandtheirimprovementoftype2diabetesmellitusbypromotingpi3kaktsignalingpathwayindbdbmice AT sheyongxin screeningofpotentialprobioticlactobacillaceaeandtheirimprovementoftype2diabetesmellitusbypromotingpi3kaktsignalingpathwayindbdbmice AT lizuming screeningofpotentialprobioticlactobacillaceaeandtheirimprovementoftype2diabetesmellitusbypromotingpi3kaktsignalingpathwayindbdbmice AT liyongli screeningofpotentialprobioticlactobacillaceaeandtheirimprovementoftype2diabetesmellitusbypromotingpi3kaktsignalingpathwayindbdbmice |